Biomaxima

Biomaxima

BMX · WAR · Healthcare / Diagnostics & Research

8.55PLN-0.01 (-0.12%)

Price History

Full chart

Market Stats

Previous Close8.56
Open8.56
Day Range8.52 – 8.56
52-Week Range9.21 – 13.25
Volume640
Market Cap41.68M
P/E (TTM)0.00
Forward P/E0.00
EPS-0.03
Dividend Yield0.00%
Beta0.31
50-Day Avg10.09
200-Day Avg11.05

About

BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland. It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements. The company also provides molecular biology and cell culture products which include real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibiotics, agaroses and molecular biology media, media and buffers for in vitro cultures, phenotypic micromatrices, plastics and small equipment, basic substrate components, and form. In addition, it offers laboratory diagnostics solutions for various areas of clinical chemistry, haematology, coagulology, immunochemistry, POCT, rapid tests, and blood collection systems; and disposable materials comprising microbiology, dispensing equipment, tubes, plugs, tripods, capillaries, equipment, aspiration-vacuum system, containers, tank for analysers, urine analysis, microscope slides, reagent tubes, and autoclave equipment. BioMaxima S.A. was founded in 1997 and is headquartered in Lublin, Poland.

Company Details

  • SectorHealthcare
  • IndustryDiagnostics & Research
  • CEOMr. Lukasz Urban
  • Employees143
  • Headquartersul. Vetterów 5, Lublin, Poland, 20-277, Poland
  • Websitehttps://www.biomaxima.com

Leadership

  • Mr. Lukasz UrbanPresident of the Management Board · b. 1971
  • Mr. Henryk LewczukCFO & Member of the Management Board
  • Mr. Piotr JanowskiCOO & Member of the Management Board
  • Zaneta HomendaChief Accounting Officer

Financials

Income Statement

Currency: PLN2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue6.67M7.16M10.49M18.82M20.97M20.44M21.97M26.98M31.57M30.82M30.49M61.61M79.09M143.87M46.79M52.85M60.90M
Growth (%)-+7.41%+46.45%+79.37%+11.41%-2.50%+7.46%+22.85%+17.01%-2.40%-1.07%+102.08%+28.37%+81.91%-67.48%+12.96%+15.24%
Cost of Revenue3.22M3.47M5.46M10.31M11.90M11.39M13.17M15.99M18.47M17.53M17.53M37.76M50.09M89.64M26.76M29.59M59.23M
Gross Profit3.45M3.70M5.03M8.51M9.06M9.05M8.80M11.00M13.10M13.29M12.95M23.85M28.99M54.23M20.02M23.26M1.67M
Gross Margin51.73%51.63%47.93%45.24%43.22%44.27%40.06%40.76%41.50%43.13%42.49%38.71%36.66%37.69%42.80%44.01%2.75%
Operating Expense2.68M2.89M3.62M6.58M7.35M8.39M7.04M9.52M12.04M13.54M12.27M13.38M15.34M19.38M19.30M21.95M1.81M
Operating Income772.75K810.00K1.41M1.93M1.71M657.80K1.76M1.47M1.06M-247.47K683.34K10.47M13.65M34.85M728.00K1.31M-135.00K
Operating Margin11.59%11.31%13.43%10.25%8.18%3.22%8.01%5.46%3.36%-0.80%2.24%17.00%17.26%24.23%1.56%2.47%-0.22%
EBITDA1.18M1.14M1.88M3.50M3.43M2.53M3.47M3.32M3.09M1.20M2.45M11.41M14.78M38.36M3.28M4.65M3.57M
EBITDA Margin17.64%15.93%17.96%18.61%16.34%12.40%15.80%12.29%9.78%3.91%8.04%18.52%18.68%26.67%7.02%8.79%5.86%
Net Income610.37K539.04K998.95K1.38M1.32M454.83K1.45M1.23M805.68K-481.98K-13.51K7.95M10.24M28.89M586.00K535.00K105.00K
Net Income Margin9.15%7.52%9.52%7.31%6.30%2.23%6.62%4.55%2.55%-1.56%-0.04%12.90%12.95%20.08%1.25%1.01%0.17%
R&D-------668.97K717.59K476.88K278.30K------
R&D as % of Total Revenue-------2.48%2.27%1.55%0.91%------
Interest Expense63.22K77.14K209.05K504.81K331.71K204.23K283.56K321.95K363.08K328.72K586.31K364.00K262.00K475.00K609.00K978.00K1.19M
Interest Expense % of Total Revenue0.95%1.08%1.99%2.68%1.58%1.00%1.29%1.19%1.15%1.07%1.92%0.59%0.33%0.33%1.30%1.85%1.95%

Balance Sheet

Currency: PLN2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets5.74M10.50M13.12M19.47M22.60M21.42M21.96M23.42M27.30M43.96M43.30M53.43M61.93M74.42M73.78M76.34M77.47M
Total Liabilities2.54M3.77M5.28M6.63M8.22M6.93M6.33M6.58M9.93M27.11M26.84M27.49M32.74M21.96M26.81M29.01M23.75M
Total Equity3.20M6.73M7.85M12.84M14.37M14.49M15.64M16.83M17.30M16.76M16.42M19.89M29.19M52.46M46.97M47.33M48.08M
Cash50.12K4.65K223.98K893.38K755.94K290.33K979.77K688.29K1.31M1.02M505.84K4.39M308.00K12.91M1.50M909.00K1.74M
Total Debt1.18M1.39M3.46M4.49M5.47M5.01M4.07M3.69M5.00M15.77M12.13M12.44M17.27M5.83M12.86M14.62M14.46M
Net Debt1.13M1.38M3.24M3.60M4.71M4.72M3.09M3.00M3.69M14.75M11.63M7.16M16.96M-7.08M11.36M13.71M12.72M

Cash Flow

Currency: PLN2009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow418.32K102.89K1.83M-5.91M1.25M561.02K2.29M1.44M1.84M2.12M4.93M3.97M-132.00K37.06M1.59M-152.00K2.34M
Investing Cash Flow-1.30M-3.90M-2.25M-876.57K-1.52M-297.71K-218.62K-625.25K-2.04M-17.16M-1.60M-1.65M-3.37M-7.83M-17.25M-759.00K1.30M
Financing Cash Flow896.52K3.75M638.88K7.46M58.45K-666.37K-1.38M-1.11M389.99K14.75M-3.85M1.48M2.11M-19.32M4.25M317.00K-2.81M
Capital Expenditure1.30M2.48M2.83M1.02M961.18K148.50K161.42K376.12K2.17M17.42M1.64M1.88M4.48M9.88M18.08M2.27M999.00K
Free Cash Flow-876.83K-2.38M-998.45K-6.94M288.25K412.51K2.13M1.06M-327.85K-15.30M3.29M2.09M-4.61M27.19M-16.49M-2.42M1.34M
Dividends Paid25.16K-----304.00K608.00K390.80K1.10M1.10M1.10M1.10M1.95M2.10M--
FCF to OCF-209.61%-2311.33%-54.49%117.28%23.07%73.53%92.94%73.87%-17.82%-721.80%66.77%52.67%3495.45%73.35%-1035.62%1593.42%57.23%
Dividend Paid to FCF-2.87%-----14.30%57.20%-119.20%-7.17%33.34%52.43%-23.78%7.17%-12.72%--

Earnings

Report DateDec 31, 2012Mar 31, 2013Jun 30, 2013Sep 30, 2013Dec 31, 2013Mar 31, 2014Jun 30, 2014Sep 30, 2014Dec 31, 2014Mar 31, 2015Jun 30, 2015Sep 30, 2015Dec 31, 2015Mar 31, 2016Jun 30, 2016Sep 30, 2016Dec 31, 2016Mar 31, 2017Jun 30, 2017Sep 30, 2017Dec 31, 2017Mar 31, 2018Jun 30, 2018Sep 30, 2018Dec 31, 2018Mar 31, 2019Jun 30, 2019Sep 30, 2019Dec 31, 2019Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Sep 29, 2023Nov 29, 2023Dec 31, 2023May 29, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024May 30, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026
EPS Estimate------------------------------------------------------
EPS Actual0.340.100.110.140.080.100.05-0.060.050.140.110.100.140.150.060.060.150.080.030.100.040.070.14-0.16-0.18-0.05-0.03-0.020.160.070.710.250.791.400.140.300.455.430.770.210.070.110.09-0.090.020.06-0.10-0.060.230.14-0.14-0.070.100.08
Surprise------------------------------------------------------
Timing------------------------------------------After-hoursAfter-hours-After-hours---After-hours----

Key Statistics & Ratios

Market Cap41.68M
Enterprise Value58.05M
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.70
Price / Book0.88
EPS-0.03
Book Value11.47
Revenue (TTM)59.74M
Gross Profit (TTM)28.68M
EBITDA3.67M
Profit Margin-0.26%
Operating Margin3.87%
Return on Equity-0.33%
Return on Assets0.57%
Shares Outstanding4.19M
Shares Float3.77M
Beta0.31
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20231×
0.50Jun 16, 2023
20221×
0.45Jun 21, 2022
20211×
0.25May 28, 2021
20171×
0.05Aug 30, 2017
20161×
0.20Aug 30, 2016
20151×
0.10Aug 28, 2015